Delivery Order SPE2DB22D6029-SPE2DB25FLTQP

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,002.72 firm fixed-price delivery order is for the supply of the drug Emgality 120 mg/ml. The contract has a completion date of May 8, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,143.72, is a firm fixed price delivery order for the pharmaceutical product Emgality 120 mg/ml. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,389.25 Firm Fixed Price delivery order is for the drug Emgality 120 mg/ml, with a completion date of July 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of the prescription medication Emgality 120 mg/ml. The $1,926.32 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Emgality 120 mg/ml pharmaceutical products from Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The $1,002.72 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical and medical supplies for military healthcare programs. The contract has no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,589.97 Firm Fixed Price Delivery Order is for the pharmaceutical product Emgality 120 mg/ml syringe. Amerisourcebergen, a major supplier of medical products to the U.S. government, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,787.20 firm-fixed-price delivery order covers the supply of the prescription drug Emgality 120 mg/ml injectable. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $2,625.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen. This is a firm-fixed-price delivery order contract with a completion date of May 20, 2024. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,097.06 firm fixed-price delivery order is for the pharmaceutical product Emgality 120 mg/ml penml. The contract has a completion date of September 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to supply a wide range of medications and medical supplies...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTQP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is a delivery order for the medication Emgality 120 mg/ml. The contract has a firm fixed price and an ultimate completion date of January 7, 2025.

Amerisourcebergen is the prime contractor on this award and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a strong track record of providing a wide range of pharmaceutical and medical supplies to various federal agencies, particularly the DLA and the Department of Justice.

Generated 4/13/25, 12:45 AM